Susquehanna International Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-455,100
| Closed | -$8.19M | – | 11531 |
|
|
2020
Q2 | $8.19M | Sell |
455,100
-47,200
| -9% | -$657K | ﹤0.01% | 2378 |
|
|
2020
Q1 | $3.58M | Buy |
502,300
+202,700
| +68% | +$2.53M | ﹤0.01% | 3021 |
|
|
2019
Q4 | $7.15M | Buy |
299,600
+59,000
| +25% | +$1.63M | ﹤0.01% | 2491 |
|
|
2019
Q3 | $6.45M | Sell |
240,600
-5,200
| -2% | -$146K | ﹤0.01% | 2418 |
|
|
2019
Q2 | $6.67M | Buy |
245,800
+33,300
| +16% | +$1.04M | ﹤0.01% | 2351 |
|
|
2019
Q1 | $7.37M | Sell |
212,500
-252,000
| -54% | -$7.27M | ﹤0.01% | 2041 |
|
|
2018
Q4 | $9.07M | Buy |
464,500
+3,400
| +0.7% | +$69.9K | ﹤0.01% | 1701 |
|
|
2018
Q3 | $12.3M | Sell |
461,100
-50,500
| -10% | -$1.65M | ﹤0.01% | 1739 |
|
|
2018
Q2 | $19.3M | Sell |
511,600
-51,700
| -9% | -$1.98M | 0.01% | 1331 |
|
|
2018
Q1 | $18.4M | Sell |
563,300
-79,400
| -12% | -$3.48M | 0.01% | 1281 |
|
|
2017
Q4 | $31.3M | Buy |
642,700
+142,900
| +29% | +$7.23M | 0.01% | 952 |
|
|
2017
Q3 | $27M | Buy |
499,800
+181,400
| +57% | +$10.6M | 0.01% | 1019 |
|
|
2017
Q2 | $17.9M | Buy |
318,400
+46,500
| +17% | +$1.86M | 0.01% | 1234 |
|
|
2017
Q1 | $10.7M | Buy |
271,900
+82,400
| +43% | +$2.62M | 0.01% | 1567 |
|
|
2016
Q4 | $4.25M | Buy |
189,500
+12,200
| +7% | +$238K | ﹤0.01% | 2680 |
|
|
2016
Q3 | $4.03M | Buy |
177,300
+107,000
| +152% | +$2.51M | ﹤0.01% | 2500 |
|
|
2016
Q2 | $1.66M | Sell |
70,300
-116,500
| -62% | -$2.88M | ﹤0.01% | 3909 |
|
|
2016
Q1 | $3.81M | Buy |
186,800
+85,700
| +85% | +$2.72M | ﹤0.01% | 2688 |
|
|
2015
Q4 | $5.2M | Buy |
101,100
+52,600
| +108% | +$2.55M | ﹤0.01% | 2490 |
|
|
2015
Q3 | $2.07M | Buy |
+48,500
| New | +$2.34M | ﹤0.01% | 4224 |
|
|
2015
Q2 | – | Sell |
-20,000
| Closed | -$759K | – | 10639 |
|
|
2015
Q1 | $759K | Buy |
+20,000
| New | +$687K | ﹤0.01% | 6308 |
|
Susquehanna International Group's PTLA Position: Q3 2020 in Review
Susquehanna International Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 425,898 shares — an estimated $7.66M sold.
Susquehanna International Group first reported a position in PTLA in Q2 2013 and held it in 25 quarters. The position peaked at $23.9M in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Susquehanna International Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Susquehanna International Group sold 425,898 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $7.66M.
- Susquehanna International Group first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 25 quarters.
- Susquehanna International Group's Portola Pharmaceuticals, Inc. position peaked at $23.9M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.